Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Qualitative Patient and Clinician Interviews Informing the Development of a Conceptual Model by Jeffrey L. Bennett, Asha Paireddy, Charlotte Cox, Megan Mayhew, Julia Stein, Teresa Gasalla, Béatrice Tugaut

Get full text

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury by Tyler L. Borko, Tyler L. Borko, Phillip Winters, Kelli M. Money, Stefan Sillau, Sadie Eggmann, Sean Selva, Alanna Ritchie, Ryan Kammeyer, Ryan Kammeyer, Gregory P. Owens, Jeffrey L. Bennett, Jeffrey L. Bennett, Amanda L. Piquet

Get full text

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica by Katherine S Given, Elizabeth G Acker, Wendy B Macklin, Dan Carlin, Gregory P. Owens, Jeffrey L Bennett

Get full text

The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population by Aaron M. Carlson, Carlos E.V. Sollero, Andrew B. Wolf, Stefan Sillau, Barrie L. Schmitt, Kelli M. Money, Kavita V. Nair, Amanda L. Piquet, Jeffrey L. Bennett

Get full text

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity by Jeffrey L. Bennett, Sean J. Pittock, Friedemann Paul, Ho Jin Kim, Sarosh R. Irani, Kevin C. O'Connor, Kristina R. Patterson, Michael A. Smith, Michele Gunsior, Nanette Mittereder, William A. Rees, Daniel Cimbora, Bruce A. C. Cree

Get full text